Arsenic, lead and other metals in tampons aren’t harmful, FDA report concludes
9 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Evidence dossier
Intelligence passport
Measured timeline
-
Detected
-
Latest coverage observed
-
Peak measured velocity
-
Evidence threshold reached
Sources (10)
-
FDA Bench Study Finds Tampon Metal Levels Too Low To Harm Usersinsights.citeline.com · 136d ago
-
FDA says trace metals found in tampons do not pose health riskYahoo · 136d ago
-
Do metals in tampons pose a health risk? A toxicological risk assessment studyNewswise · 136d ago
-
Metals in tampons pose no health concern, FDA saysUSA Today · 136d ago
-
Can Arsenic, Lead and Other Metals In Tampons Pose A Health Risk? FDA Says NoHealth and Me · 136d ago
-
Heavy Metals in Tampons Aren’t Cause for Concern, Regulators SayBloomberg.com · 136d ago
-
Heavy metals in tampons aren’t cause for concern, US regulators sayThe Straits Times · 136d ago
-
FDA Bench Study Finds Tampon Metal Levels Too Low To Harm Usersinsights.citeline.com · 136d ago
-
Menstrual Product Options, Facts, and Safe Usefda.gov · 136d ago
-
Arsenic, lead and other metals in tampons aren’t harmful, FDA report concludesNBC News · 136d ago
Where it stands
- Velocity & Diffusion: Coverage exploded across 9 distinct news outlets with 10 published articles, achieving a live velocity of 8.
- Primary Driver: 9 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
- Predictive Outlook: Archynetys algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"Arsenic, lead and other metals in tampons aren’t harmful, FDA report concludes" is generating significant coverage in the Business category, with 10 articles from 9 distinct sources tracked by Archynetys so far.
Outlets currently covering the story include insights.citeline.com, Yahoo, Newswise and USA Today. Archynetys measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
Synthesized from multi-source international reporting and live coverage telemetry under Archynetys open intelligence methodology.
Generated by Archynetys's extractive engine from coverage metadata only — no AI-written claims. Updated 133d ago.
Answered
Why is "Arsenic, lead and other metals in tampons aren’t harmful, FDA report concludes" trending?
Because 9 independent news sources published 10 articles about it in a short window — a coverage burst Archynetys classifies as a trend.
How does Archynetys measure this trend?
Archynetys scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Topics
Related trends
The GLP-1 boom has a dark side
The FDA has ordered new eye-risk warnings on a dozen GLP-1 drugs including Ozempic and Zepbound, escalating safety scrutiny of the blockbuster weight-loss class.
FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
FDA rejects Summit's ivonescimab, halting the first PD-1xVEGF bispecific antibody from reaching the US market.
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
The FDA has ordered new warning labels on blockbuster GLP-1 drugs Ozempic and Zepbound over a rare eye condition linked to sudden blindness, shaking confidence in the red-hot weight-loss market.
‘I’m destroyed.’ Owner speaks on E. coli outbreak that shut down SLO County farm
Brookshire Farms faces shutdown after an E. coli outbreak sickens fifteen, including three children with kidney failure, and co‑owner declares 'I'm destroyed'.
DEA And Marijuana Rescheduling Opponents File Final Briefs In Hearing Ahead Of Judge's Decision
Judge's decision looms on marijuana rescheduling as opponents file final briefs.
Breakthrough: FDA Approves First Drug Offering a 'Functional Cure' For Chronic Hepatitis B
The FDA approved Hibsago, the first drug offering a functional cure for chronic hepatitis B, after clinical trials showed 19% of patients achieved undetectable virus levels that persisted after treatment ended.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.